Join
Live feed
·
INSIDERFilingvia Quantisnow
Atea Pharmaceuticals Inc. logo

President, CEO, and Chairman Sommadossi Jean-Pierre was granted 99,517 shares, covered exercise/tax liability with 88,601 shares and converted options into 173,467 shares, increasing direct ownership by 158% to 300,940 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AVIR (Atea Pharmaceuticals Inc.) and more on Quantisnow.

President, CEO, and Chairman Sommadossi Jean-Pierre was granted 99,517 shares, covered exercise/tax liability with 88,601 shares and converted options into 173,467 shares, increasing direct ownership by 158% to 300,940 units (SEC Form 4) | Quantisnow